Table of Contents Author Guidelines Submit a Manuscript
Computational and Mathematical Methods in Medicine
Volume 2014 (2014), Article ID 160520, 14 pages
http://dx.doi.org/10.1155/2014/160520
Research Article

Structural Equation Modeling for Analyzing Erythrocyte Fatty Acids in Framingham

1Health Diagnostic Laboratory Inc., Richmond, VA 23219, USA
2Department of Internal Medicine, Sanford School of Medicine, University of South Dakota, Sioux Falls, SD 57105, USA
3Department of Mathematics and Statistics, South Dakota State University, Brookings, SD 57007, USA
4Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA
5Department of Statistics, University of Akron, Akron, OH 44325, USA
6Department of Biostatistics, Boston University School of Public Health, Boston, MA 02218, USA
7Department of Mathematics and Statistics, Boston University, Boston, MA 02215, USA
8Framingham Heart Study, Framingham, MA 01702, USA
9OmegaQuant Analytics, Sioux Falls, SD 57107, USA

Received 26 December 2013; Revised 28 February 2014; Accepted 28 February 2014; Published 15 April 2014

Academic Editor: Zhenyu Jia

Copyright © 2014 James V. Pottala et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Albert, H. Campos, M. J. Stampfer et al., “Blood levels of long-chain n-3 fatty acids and the risk of sudden death,” The New England Journal of Medicine, vol. 346, no. 15, pp. 1113–1118, 2002. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Wang, W. S. Harris, M. Chung et al., “n-3 Fatty acids from fish or fish-oil supplements, but not α-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review,” American Journal of Clinical Nutrition, vol. 84, no. 1, pp. 5–17, 2006. View at Google Scholar · View at Scopus
  3. J. V. Pottala, S. Garg, B. E. Cohen, M. A. Whooley, and W. S. Harris, “Blood eicosapentaenoic and docosahexaenoic acids predict all-cause mortality in patients with stable coronary heart disease: the heart and soul study,” Circulation: Cardiovascular Quality and Outcomes, vol. 3, no. 4, pp. 406–412, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. W. S. Harris, D. Mozaffarian, E. Rimm et al., “Omega-6 fatty acids and risk for cardiovascular disease: a science advisory from the American Heart Association nutrition subcommittee of the council on nutrition, physical activity, and metabolism; council on cardiovascular nursing; and council on epidemiology and prevention,” Circulation, vol. 119, no. 6, pp. 902–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. N. T. Bendsen, S. Stender, P. B. Szecsi et al., “Effect of industrially produced trans fat on markers of systemic inflammation: evidence from a randomized trial in women,” Journal of Lipid Research, vol. 52, no. 10, pp. 1821–1828, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. B. Barham, M. B. Edens, A. N. Fonteh, M. M. Johnson, L. Easter, and F. H. Chilton, “Addition of eicosapentaenoic acid to γ-linolenic acid-supplemented diets prevents serum arachidonic acid accumulation in humans,” Journal of Nutrition, vol. 130, no. 8, pp. 1925–1931, 2000. View at Google Scholar · View at Scopus
  7. J. R. Marszalek and H. F. Lodish, “Docosahexaenoic acid, fatty acid-interacting proteins, and neuronal function: breastmilk and fish are good for you,” Annual Review of Cell and Developmental Biology, vol. 21, pp. 633–657, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Mozaffarian, A. Ascherio, F. B. Hu et al., “Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men,” Circulation, vol. 111, no. 2, pp. 157–164, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. J. T. Mocking, J. Assies, A. Lok et al., “Statistical methodological issues in handling of fatty acid data: percentage or concentration, imputation and indices,” Lipids, vol. 47, no. 5, pp. 541–547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. C. K. Chow, “Fatty acid composition of plasma phospholipids and risk of prostate cancer,” The American Journal of Clinical Nutrition, vol. 89, no. 6, pp. 1946–1947, 2009. View at Google Scholar · View at Scopus
  11. F. L. Crowe, “Reply to CK Chow,” American Journal of Clinical Nutrition, vol. 89, no. 6, pp. 1946–1947, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. K. E. Bradbury, C. Murray Skeaff, T. J. Green, A. R. Gray, and F. L. Crowe, “The serum fatty acids myristic acid and linoleic acid are better predictors of serum cholesterol concentrations when measured as molecular percentages rather than as absolute concentrations,” American Journal of Clinical Nutrition, vol. 91, no. 2, pp. 398–405, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Harris, “Omega-3 fatty acids in cardiac biopsies from heart transplantation patients—correlation with erythrocytes and response to supplementation,” Circulation, vol. 110, no. 12, pp. 1645–1649, 2004. View at Google Scholar · View at Scopus
  14. L. Hodson, C. M. Skeaff, and B. A. Fielding, “Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake,” Progress in Lipid Research, vol. 47, no. 5, pp. 348–380, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. M. A. Beydoun, J. S. Kaufman, J. Ibrahim, J. A. Satia, and G. Heiss, “Measurement error adjustment in essential fatty acid intake from a food frequency questionnaire: alternative approaches and methods,” BMC Medical Research Methodology, vol. 7, article 41, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Tournoud, R. Ecochard, J. Iwaz, J.-P. Steghens, G. Bellon, and I. Durieu, “Structural equations to model relationships between pulmonary function, fatty acids and oxidation in cystic fibrosis,” Scandinavian Journal of Clinical and Laboratory Investigation, vol. 69, no. 1, pp. 36–44, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. J. C. N. Chan, P. C. Y. Tong, and J. A. J. H. Critchley, “The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk,” Seminars in Vascular Medicine, vol. 2, no. 1, pp. 45–57, 2002. View at Google Scholar · View at Scopus
  18. J. Bradbury, L. Brooks, and S. P. Myers, “Are the adaptogenic effects of omega 3 fatty acids mediated via inhibition of proinflammatory cytokines?” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 209197, 14 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. W. F. Wilson, R. B. D'Agostino, D. Levy, A. M. Belanger, H. Silbershatz, and W. B. Kannel, “Prediction of coronary heart disease using risk factor categories,” Circulation, vol. 97, no. 18, pp. 1837–1847, 1998. View at Google Scholar · View at Scopus
  20. H. W. Marsh, B. Muthén, T. Asparouhov et al., “Exploratory structural equation modeling, integrating CFA and EFA: application to students' evaluations of university teaching,” Structural Equation Modeling, vol. 16, no. 3, pp. 439–476, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. H. W. Marsh, O. Lüdtke, B. Muthén et al., “A new look at the big five factor structure through exploratory structural equation modeling,” Psychological Assessment, vol. 22, no. 3, pp. 471–491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. W. B. Kannel, M. Feinleib, and P. M. McNamara, “An investigation of coronary heart disease in families. The Framingham offspring study,” American Journal of Epidemiology, vol. 110, no. 3, pp. 281–290, 1979. View at Google Scholar · View at Scopus
  23. S. F. Quan, B. V. Howard, C. Iber et al., “The Sleep Heart Health Study: design, rationale, and methods,” Sleep, vol. 20, no. 12, pp. 1077–1085, 1997. View at Google Scholar · View at Scopus
  24. W. S. Harris, J. V. Pottala, R. S. Vasan et al., “Changes in erythrocyte membrane trans and marine fatty acids between 1999 and 2006 in older Americans,” Journal of Nutrition, vol. 142, no. 7, pp. 1297–1303, 2012. View at Google Scholar
  25. A. Skrondal and S. Rabe-Hesketh, Generalized Latent Variable Modeling: Multilevel, Longitudinal, and Structural Equation Modeling, Chapman & Hall, Boca Raton, Fla, USA, 2004.
  26. R. B. Kline, Principles and Practice of Structural Equation Modeling, The Guilford Press, New York, NY, USA, 2nd edition, 2005.
  27. K. V. Mardia, “Applications of some measures of multivariate skewness and kurtosis in testing normality and robustness studies,” Sankhya: The Indian Journal of Statistics B, vol. 36, pp. 115–128, 1974. View at Google Scholar
  28. L. K. Muthen and B. O. Muthen, Mplus User's Guide, Muthen & Muthen, Los Angeles, Calif, USA, 6th edition, 2010.
  29. H. F. Kaiser, “An index of factorial simplicity,” Psychometrika, vol. 39, no. 1, pp. 31–36, 1974. View at Publisher · View at Google Scholar · View at Scopus
  30. M. A. Pett, N. R. Lackey, and J. J. Sullivan, Making Sense of Factor Analysis: The Use of Factor Analysis for Instrument Development in Health Care Research, Sage Publications, Thousand Oaks, Calif, USA, 2003.
  31. R. Johnson and D. Wichern, Applied Multivariate Statistical Analysis, Pearson Education, Upper Saddle River, NJ, USA, 6th edition, 2007.
  32. A. Satorra and P. M. Bentler, “A scaled difference chi-square test statistic for moment structure analysis,” Psychometrika, vol. 66, no. 4, pp. 507–514, 2001. View at Google Scholar · View at Scopus
  33. J. H. Steiger and J. M. Lind, “Statistically based tests for the number of common factors,” in Proceedings of the Annual Meeting Psychometric Society, Iowa City, IA, Iowa, USA, 1980.
  34. P. M. Bentler, “Comparative fit indexes in structural models,” Psychological Bulletin, vol. 107, no. 2, pp. 238–246, 1990. View at Google Scholar · View at Scopus
  35. G. W. Cheung and R. B. Rensvold, “The effects of model parsimony and sampling error on the fit of structural equation models,” Organizational Research Methods, vol. 4, no. 3, pp. 236–264, 2001. View at Google Scholar · View at Scopus
  36. G. Schwarz, “Estimating the dimension of a model,” Annals of Statistics, vol. 6, pp. 461–464, 1978. View at Google Scholar
  37. H. Akaike, “Information theory and an extension of maximum likelihood principal,” in Proceedings of the 2nd International Symposium of Information Theory and Control, Akademia Kiado, Budapest, Hungary, 1973.
  38. F. Chen, K. A. Bollen, P. Paxton, P. J. Curran, and J. B. Kirby, “Improper solutions in structural equation models: causes, consequences, and strategies,” Sociological Methods and Research, vol. 29, no. 4, pp. 468–508, 2001. View at Google Scholar · View at Scopus
  39. M. E. Rumawas, J. T. Dwyer, N. M. Mckeown, J. B. Meigs, G. Rogers, and P. F. Jacques, “The development of the mediterranean-style dietary pattern score and its application to the american diet in the framingham offspring cohort,” Journal of Nutrition, vol. 139, no. 6, pp. 1150–1156, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Portolesi, B. C. Powell, and R. A. Gibson, “Competition between 24:5n-3 and ALA for Δ6 desaturase may limit the accumulation of DHA in HepG2 cell membranes,” Journal of Lipid Research, vol. 48, no. 7, pp. 1592–1598, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. W. S. Harris, J. V. Pottala, S. M. Lacey et al., “Clinical correlates and heritability of erythrocyte eicosapentaenoic and docosahexaenoic acid content in the Framingham Heart Study,” Atherosclerosis, vol. 225, no. 2, pp. 425–431, 2012. View at Google Scholar
  42. W. S. Harris and C. Von Schacky, “The Omega-3 Index: a new risk factor for death from coronary heart disease?” Preventive Medicine, vol. 39, no. 1, pp. 212–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  43. J. V. Pottala, J. A. Talley, S. W. Churchill, D. A. Lynch, C. von Schacky, and W. S. Harris, “Red blood cell fatty acids are associated with depression in a case-control study of adolescents,” Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 86, no. 4-5, pp. 161–165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. A. P. Simopoulos, “The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases,” Experimental Biology and Medicine, vol. 233, no. 6, pp. 674–688, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. W. E. M. Lands, “Diets could prevent many diseases,” Lipids, vol. 38, no. 4, pp. 317–321, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. W. S. Harris, “The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses,” Current Atherosclerosis Reports, vol. 8, no. 6, pp. 453–459, 2006. View at Publisher · View at Google Scholar · View at Scopus
  47. J. Kröger and M. B. Schulze, “Recent insights into the relation of Δ5 desaturase and Δ6 desaturase activity to the development of type 2 diabetes,” Current Opinion in Lipidology, vol. 23, no. 1, pp. 4–10, 2012. View at Publisher · View at Google Scholar · View at Scopus
  48. J. G. Robinson, N. Ijioma, and W. Harris, “Omega-3 fatty acids and cognitive function in women,” Women's Health (London, England), vol. 6, no. 1, pp. 119–134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. J. V. Pottala, K. Yaffe, J. G. Robinson et al., “Higher RBC EPA + DHA corresponds with larger total brain and hippocampal volumes: WHIMS-MRI Study,” Neurology, vol. 82, no. 5, pp. 435–442, 2014. View at Google Scholar
  50. Z. S. Tan, W. S. Harris, A. S. Beiser et al., “Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging,” Neurology, vol. 78, no. 9, pp. 658–664, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. R. Farzaneh-Far, J. Lin, E. S. Epel, W. S. Harris, E. H. Blackburn, and M. A. Whooley, “Association of marine omega-3 fatty acid levels with telomeric aging in patients with coronary heart disease,” JAMA—Journal of the American Medical Association, vol. 303, no. 3, pp. 250–257, 2010. View at Publisher · View at Google Scholar · View at Scopus